Natco Pharma Ltd Financials Statements

Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios

Consolidate
Standalone
Financial Year
Mar '24
Dec '23
Sep '23
Jun '23
Mar '23
Total Qtr Revenue cr
1,110.30
795.60
1,060.80
1,160.20
926.90
Other Income Qtr Cr42.0037.0029.4019.7029.00
Operating Revenues Qtr1,068.30758.601,031.401,140.50897.90

*All values are in Cr.

Operating Expenses Qtr
571.00
490.50
573.40
612.50
558.80
Operating Profit Qtr
497.30
268.10
458.00
528.00
339.10
EBIDT Qtr Cr
539.30
305.10
487.40
547.70
368.10
Depreciation Qtr
55.50
44.20
43.60
43.50
41.00
Net Profit Qtr
386.30
212.70
369.00
420.30
275.80
Basic EPS Qtr
21.56
11.88
20.60
23.26
15.11
Open Demat Account
or Resume your Application
+91 -

personImage